Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Glucosamine-6-phosphate deaminase (EC 184.108.40.206) is an allosteric enzyme that catalyzes the reversible conversion of D-glucosamine-6-phosphate into D-fructose-6-phosphate and ammonium (Arreola et al., 2003. Additionally we are shipping Glucosamine-6-Phosphate Deaminase 1 Proteins (13) and Glucosamine-6-Phosphate Deaminase 1 Kits (3) and many more products for this protein.
Showing 10 out of 84 products:
Caenorhabditis elegans (C. elegans) Polyclonal GNPDA1 Primary Antibody for WB - ABIN2783314
Arreola, Valderrama, Morante, Horjales: Two mammalian glucosamine-6-phosphate deaminases: a structural and genetic study. in FEBS letters 2003
Human Polyclonal GNPDA1 Primary Antibody for IHC, IHC (p) - ABIN4315256
Ek, Andréasson, Hober, Kampf, Pontén, Uhlén, Merz, Borrebaeck: From gene expression analysis to tissue microarrays: a rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies. in Molecular & cellular proteomics : MCP 2006
Human Polyclonal GNPDA1 Primary Antibody for EIA, IF - ABIN499896
Wolosker, Kline, Bian, Blackshaw, Cameron, Fralich, Schnaar, Snyder: Molecularly cloned mammalian glucosamine-6-phosphate deaminase localizes to transporting epithelium and lacks oscillin activity. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1998
The silencing of PGI/AMF (show GPI Antibodies) decreased the levels of phosphorylated Akt (show AKT1 Antibodies) (-71.9%, P<0.001) compared with the scrambled siRNA, as well as the levels of the stemness marker, SOX2 (show SOX2 Antibodies) (-61.7%, P<0.01). Taken together, these findings suggest that PGI/AMF (show GPI Antibodies) silencing decreases migration, tumorsphere formation as well as the proportion of on the side population cells in glioblastoma U87 cells.
NLK (show NLK Antibodies) is able to promote cell proliferation and type II collagen (show COL2A1 Antibodies) synthesis during in vitro chondrocyte propagation.
Suggest tha AMF/PGI (show GPI Antibodies)-mediated tumorigenesis occurs through MAPK-ERK (show MAPK1 Antibodies) signaling in endometrial carcinoma.
Study supports a role for AMF (show GPI Antibodies) mediating epithelial-mesenchymal transition in endometrial cancer (EC) through MAPK (show MAPK1 Antibodies) signaling. Therefore, AMF (show GPI Antibodies) may provide a potential prognostic and therapeutic target in preventing EC progression.
Results showed an increase in GPI and AMFR (show AMFR Antibodies) in clear cell-renal cell carcinoma (show MOK Antibodies) cells, and their colocalization on plasma membrane. Kaplan-Meier curves showed significant differences in survival among groups of patients with high versus low GPI.
The association of ENO1 (show ENO1 Antibodies) and GPI with postthaw sperm viability and motility was confirmed using Pearson's linear correlation. ENO1 (show ENO1 Antibodies) and GPI can be used as markers of human sperm freezability before starting the cryopreservation procedure.
High GPI expression is associated with metastatic phenotype of breast cancer.
PGI (show BGN Antibodies) is a moonlighting protein that functions as a cytosolic enzyme involved in glycolysis and gluconeogenesis, and as cytokine through binding to its cell surface receptor.
Serum anti-GPI autoantibodies are useful for the diagnosis of rheumatoid arthritis in Chinese patients.
Findings suggest that autocrine motility factor (AMF (show GPI Antibodies))-HER2 (show ERBB2 Antibodies) interaction might be a novel target for therapeutic management of patients with breast cancer, whose disease is resistant to trastuzumab.
This gene belongs to the GPI family whose members encode multifunctional phosphoglucose isomerase proteins involved in energy pathways. The protein encoded by this gene is a dimeric enzyme that catalyzes the reversible isomerization of glucose-6-phosphate and fructose-6-phosphate. The protein functions in different capacities inside and outside the cell. In the cytoplasm, the gene product is involved in glycolysis and gluconeogenesis, while outside the cell it functions as a neurotrophic factor for spinal and sensory neurons. Defects in this gene are the cause of nonspherocytic hemolytic anemia and a severe enzyme deficiency can be associated with hydrops fetalis, immediate neonatal death and neurological impairment.
glucosamine-6-phosphate deaminase 1
, glucosamine-6-phosphate isomerase 1
, Glucosamine-6-phosphate deaminase 1
, GNPDA 1
, glcN6P deaminase 1
, putative glucosamine-6-phosphate isomerase
, putative Glucosamine-6-phosphate isomerase
, glucose-6-phosphate isomerase
, autocrine motility factor
, glucose phosphate isomerase
, hexose monophosphate isomerase
, hexosephosphate isomerase
, phosphoglucose isomerase
, phosphohexose isomerase
, sperm antigen 36
, sperm antigen-36